Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity.
Ioannis V KostopoulosDespina FotiouMaria GavriatopoulouPantelis RousakisIoannis Ntanasis-StathopoulosChrysanthi PanteliPanagiotis MalandrakisMagdalini MigkouNikolaos AngelisNikolaos KanelliasEvangelos Eleutherakis-PapaiakovouFoteini TheodorakakouMaria KrevvataEvangelos TerposMeletios- Athanasios DimopoulosOurania E TsitsilonisEfstathios KastritisPublished in: Blood cancer journal (2024)